Intermediate‐term survival and quality of life outcomes in patients with advanced colorectal liver metastases undergoing associating liver partition and portal vein ligation for staged hepatectomy

[1]  U. Neumann,et al.  Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity , 2017, Annals of surgery.

[2]  C. Punt,et al.  Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: A case‐matched comparison with palliative systemic therapy , 2017, Surgery.

[3]  V. Ardiles,et al.  Patient Survival After Simultaneous ALPPS and Colorectal Resection , 2017, World Journal of Surgery.

[4]  D. Raptis,et al.  Meta‐analysis of associating liver partition with portal vein ligation and portal vein occlusion for two‐stage hepatectomy , 2016, The British journal of surgery.

[5]  K. Vogt,et al.  The many faces of ALPPS: surgical indications and techniques among surgeons collaborating in the international registry. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[6]  B. Isaksson,et al.  Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases – Intermediate oncological results , 2016 .

[7]  P. Fayers,et al.  Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. , 2016, Journal of clinical epidemiology.

[8]  D. Nagorney,et al.  Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[9]  V. Ardiles,et al.  Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center. , 2015, Annals of surgery.

[10]  H. Schlitt,et al.  Long-term results after in-situ split (ISS) liver resection , 2015, Langenbeck's Archives of Surgery.

[11]  K. Bertens,et al.  Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases? , 2015, Surgery.

[12]  K. Bertens,et al.  ALPPS: challenging the concept of unresectability--a systematic review. , 2015, International journal of surgery.

[13]  W. Bechstein,et al.  Systematic Review and Meta-Analysis of Feasibility, Safety, and Efficacy of a Novel Procedure: Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy , 2015, Annals of Surgical Oncology.

[14]  C. Tschuor,et al.  ALPPS: From Human to Mice Highlighting Accelerated and Novel Mechanisms of Liver Regeneration , 2014, Annals of surgery.

[15]  D. Raptis,et al.  Early Survival and Safety of ALPPS: First Report of the International ALPPS Registry , 2014, Annals of surgery.

[16]  J. Blazeby,et al.  Patient‐reported outcomes in long‐term survivors of metastatic colorectal cancer needing liver resection , 2014, The British journal of surgery.

[17]  C. Tschuor,et al.  ALPPS Offers a Better Chance of Complete Resection in Patients with Primarily Unresectable Liver Tumors Compared with Conventional-Staged Hepatectomies: Results of a Multicenter Analysis , 2014, World Journal of Surgery.

[18]  S. Nadalin,et al.  Indications and Limits for Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS). Lessons Learned from 15 Cases at a Single Centre , 2014, Zeitschrift für Gastroenterologie.

[19]  M. Donati,et al.  ALPPS for Patients with Colorectal Liver Metastases: Effective Liver Hypertrophy, but Early Tumor Recurrence , 2014, World Journal of Surgery.

[20]  M. Paganelli,et al.  Defining indications to ALPPS procedure: technical aspects and open issues , 2014, Updates in Surgery.

[21]  M. Hollands,et al.  A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. , 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[22]  J. Shindoh,et al.  Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. , 2013, Journal of the American College of Surgeons.

[23]  O. M. Torres,et al.  Ligadura da veia porta associada à bipartição do fígado para hepatectomia em dois estágios (ALPPS): experiência brasileira , 2013 .

[24]  T. Chua,et al.  Summary outcomes of two‐stage resection for advanced colorectal liver metastases , 2013, Journal of surgical oncology.

[25]  G. Fürst,et al.  In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two‐stage liver resection , 2013, The British journal of surgery.

[26]  M. Machado,et al.  Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): the Brazilian experience. , 2013, Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery.

[27]  V. Ardiles,et al.  Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS): Tips and Tricks , 2013, Journal of Gastrointestinal Surgery.

[28]  S. Nadalin,et al.  ALPPS in Right Trisectionectomy: a Safe Procedure to Avoid Postoperative Liver Failure? , 2013, Journal of Gastrointestinal Surgery.

[29]  P. Bachellier,et al.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. , 2012, Annals of surgery.

[30]  J. Vauthey,et al.  Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost? , 2012, Annals of surgery.

[31]  V. Ardiles,et al.  Our initial experience with ALPPS technique: encouraging results , 2012, Updates in Surgery.

[32]  P. Fayers,et al.  Patient-reported outcomes after hepatic resection of colorectal cancer metastases. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  W. Oyen,et al.  Long‐term global quality of life in patients treated for colorectal liver metastases , 2011, The British journal of surgery.

[34]  M. Gönen,et al.  Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. , 2010, Journal of the American College of Surgeons.

[35]  N. Aaronson,et al.  Effects of mode of administration (MOA) on the measurement properties of the EORTC QLQ-C30: a randomized study , 2010, Health and quality of life outcomes.

[36]  D. Laurent,et al.  A randomized study , 2010 .

[37]  M. Choti,et al.  Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis: An International Multi-Institutional Analysis of 1669 Patients , 2009, Annals of surgery.

[38]  T. Wobbes,et al.  Quality of life after surgical treatment of colorectal liver metastases , 2006, The British journal of surgery.

[39]  Frcsc Paul D. Greig MD,et al.  Survival After Hepatic Resection for Colorectal Metastases: A 10-Year Experience , 2006, Annals of Surgical Oncology.

[40]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[41]  H. Bismuth,et al.  Two-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver Tumors , 2000, Annals of surgery.

[42]  F. Lévi,et al.  Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. , 1996, Annals of surgery.

[43]  Andrew Bottomley,et al.  EORTC QLQ-C30 Scoring Manual , 1995 .